Delgado-Miguel Carlos, Miguel-Ferrero Miriam, Muñoz-Serrano Antonio, Díaz Mercedes, López-Gutiérrez Juan Carlos, Torre Carlos De la
Department of Pediatric Surgery, La Paz Children's Hospital, Madrid, Spain.
Department of Pediatric Plastic Surgery, La Paz Children's Hospital, Madrid, Spain.
Surg J (N Y). 2022 Aug 16;8(3):e187-e191. doi: 10.1055/s-0042-1755622. eCollection 2022 Jul.
Autologous tissue transfers have been used in chest wall reconstruction for decades, with high morbidity. Recently, acellular dermal matrices (ADMs) have emerged as an alternative. The aim of this article is to report our initial experience in the reconstruction of malformative chest wall deformities with ADM. A prospective observational study was performed in patients with malformative chest wall deformities, who were reconstructed with ADM at our institution between 2018 and 2020. We analyzed demographic variables, surgical features, postoperative complications, and cosmetic results at 12 months' follow- up. Four male patients were included (median age: 16 years). Two patients had bilateral costal anomalies, one patient had a unilateral chest deformity, and one patient had Poland syndrome. In all patients, blunt dissection of the subcutaneous cellular tissue overlying the defect was performed through 2.5 to 3 cm skin incisions, creating a pouch. Afterwards, several sheets of Integra Single Layer were placed in the pouch, to replace the volume defect. All patients were discharged same-day. No postoperative infections, hematomas, or seromas were observed. Only one patient presented with a partial surgical wound dehiscence. Revisions were performed at 1, 3, 6, and 12 months. All 4 patients were satisfied with the cosmetic outcome (Nuss Questionnaire: median score: 16 points; Q1-Q3: 22-26). The use of ADM in malformative chest wall deformities reconstruction has not been previously described in children. This study demonstrates that the use of ADM is a safe and reliable technique. However, more studies with long-term follow-up are warranted.
自体组织移植已用于胸壁重建数十年,但发病率较高。近年来,脱细胞真皮基质(ADM)已成为一种替代方法。本文旨在报告我们使用ADM重建胸壁畸形的初步经验。
对胸壁畸形患者进行了一项前瞻性观察研究,这些患者于2018年至2020年在我们机构接受了ADM重建。我们分析了人口统计学变量、手术特征、术后并发症以及12个月随访时的美容效果。
纳入了4名男性患者(中位年龄:16岁)。2例患者有双侧肋骨异常,1例患者有单侧胸部畸形,1例患者有波兰综合征。所有患者均通过2.5至3厘米的皮肤切口对缺损上方的皮下细胞组织进行钝性分离,形成一个囊袋。然后,将几片Integra单层材料放入囊袋中,以替代容积缺损。所有患者均在当天出院。未观察到术后感染、血肿或血清肿。只有1例患者出现部分手术切口裂开。在1、3、6和12个月时进行了修复。所有4例患者对美容效果均满意(努斯问卷:中位得分:16分;第一四分位数至第三四分位数:22 - 26)。
此前尚未有关于在儿童胸壁畸形重建中使用ADM的描述。本研究表明,使用ADM是一种安全可靠的技术。然而,需要更多进行长期随访的研究。